Everolimus Safety Profile in Liver Transplant Recipients With 3-Year Exposure in the H2304 Core and Extension Study.

被引：0
|
作者：
Saliba, F. [1 ]
Rogiers, X. [1 ]
Chapman, W. [1 ]
Caicedo, L. [1 ]
Alsina, A. [1 ]
Teperman, L. [1 ]
Junge, G. [1 ]
Rauer, B. [1 ]
Dong, G. [1 ]
De Simone, P. [1 ]
机构：
[1] H2304E1 Study Grp, Villejuif, France
来源：
LIVER TRANSPLANTATION | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-310
引用
收藏
页码：S247 / S248
页数：2
相关论文
共 50 条
  • [1] Long-Term Superior Renal Function With Everolimus and Reduced Tacrolimus in Liver Transplant Recipients: 3-Year Results from the H2304 Extension Study
    Fischer, Lutz
    Saliba, Faouzi
    Kaiser, Gernot M.
    De Carlis, Luciano
    Metselaar, Herold J.
    Nevens, Frederik
    Duvoux, Christophe
    Dong, Gaohong
    Rauer, Barbara
    Junge, Guido
    LIVER TRANSPLANTATION, 2014, 20 : S171 - S172
  • [2] Long-Term Safety With Everolimus-Based Regimen in De Novo Liver Transplant Recipients: 4-Year Results From The Extension of H2304 Study.
    Saliba, F.
    Rogiers, X.
    Chapman, W.
    Caicedo, L.
    Alsina, A.
    Teperman, L.
    Junge, G.
    Rauer, B.
    Dong, G.
    De Simone, P.
    TRANSPLANTATION, 2014, 98 : 161 - 161
  • [3] Long-Term Safety With Everolimus-Based Regimen in De Novo Liver Transplant Recipients: 4-Year Results From The Extension of H2304 Study.
    Saliba, F.
    Rogiers, X.
    Chapman, W.
    Caicedo, L.
    Alsina, A.
    Teperman, L.
    Junge, G.
    Rauer, B.
    Dong, G.
    De Simone, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 161 - 161
  • [4] Exposure-Response Analysis of Everolimus and Tacrolimus in De Novo Liver Transplant Recipients: 24-Month Results from the H2304 Study.
    Fischer, L.
    Kaiser, G. M.
    Huang, M. A.
    Toselli, L.
    Durand, F.
    Heaton, N.
    Shetty, K.
    Klintmalm, G.
    Dong, G.
    Lopez, P.
    Junge, G.
    Kovarik, J. M.
    LIVER TRANSPLANTATION, 2013, 19 : S148 - S148
  • [5] Evaluation of the Major Adverse Cardiac Events Risk with Everolimus-Based Calcineurin Inhibitor Reduction or Withdrawal Regimen in Liver Transplant Recipients: 3-Year Post-Hoc Analysis of the Randomized H2304 Extension Study.
    Bernhardt, P.
    Dong, G.
    Lopez, P.
    Hustache, G.
    Bader, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 234 - 234
  • [6] Everolimus Monotherapy after Tacrolimus Withdrawal at Month 4 after Liver Transplantation: 3-Year Results from the H2304 Study Extension.
    Fung, J.
    Metselaar, H. J.
    Koneru, B.
    Bartels, M.
    McCaughan, G.
    Chavin, K.
    Dong, G.
    Rauer, B.
    Junge, G.
    Fischer, L.
    LIVER TRANSPLANTATION, 2014, 20 : S106 - S106
  • [7] Effects of Everolimus and Tacrolimus Exposure on Efficacy and Renal Function in Liver Transplant Recipients at 24 Months in a Randomized Trial (H2304)
    Fischer, L.
    Kaiser, G.
    Koneru, B.
    Toselli, L.
    Durand, F.
    Heaton, N.
    Shetty, K.
    Dong, G.
    Lopez, P.
    Junge, G.
    Kovarik, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 117 - 118
  • [8] Assessment of Cardiovascular Disease Risk in Liver Transplant Recipients with Everolimus-Based Calcineurin Inhibitor Reduction or Withdrawal Regimen: A 3-Year Post-Hoc Analysis from the Randomized H2304 Extension Study
    Bernhardt, Peter
    Dong, Gaohong
    Lopez, Patricia
    Hustache, Gregory
    Bader, Giovanni
    TRANSPLANTATION, 2016, 100 : S81 - S81
  • [9] A 3-YEAR POST-HOC ANALYSIS OF THE RANDOMIZED H2304 EXTENSION STUDY EVALUATION OF THE MAJOR ADVERSE CARDIAC EVENTS RISK WITH EVEROLIMUS-BASED CALCINEURIN INHIBITOR REDUCTION OR WITHDRAWAL REGIMEN IN LIVER TRANSPLANT RECIPIENTS
    Bernhardt, P.
    Lopez, P.
    Kroeger, I.
    Hustache, G.
    Bader, G.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 21 - 21
  • [10] Renal Function with Everolimus and Reduced Tacrolimus in De Novo Liver Transplant Recipients: 12 Month Results of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    LIVER TRANSPLANTATION, 2012, 18 : S85 - S86
12345